Frontlight ResearchEarly access
Trial site
University of California, Los Angeles (UCLA)
- 7running trials
- 1closed trial
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Colorectal cancer4 trials
- Gastric and oesophageal cancer3 trials
- Lung cancer3 trials
- Endometrial cancer2 trials
- Pancreatic cancer2 trials
- Bladder cancer1 trial
- Diffuse large B-cell lymphoma1 trial
- Liver and biliary tract cancer1 trial
- Ovarian cancer1 trial
- Prostate cancer1 trial
- Phase
- Phase 14 trials
- Phase 22 trials
- Phase 2/31 trial
- Phase 31 trial
- Status
- Active, not recruiting5 trials
- Recruiting2 trials
- Completed1 trial
- Lead sponsor
- Eli Lilly and Company3 trials
- Acrivon Therapeutics1 trial
- Karyopharm Therapeutics Inc1 trial
- Pieris Pharmaceuticals, Inc.1 trial
- Seattle Project Corporation1 trial
- and 1 more
Running trials
Recruiting
Active, not recruiting
A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Active, not recruiting
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
Active, not recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Recruiting
Active, not recruiting
Active, not recruiting
Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer1 recruiting
- Endometrial cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Prostate cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026